This aligns with a previous research showing that ACBD3 is among the most downregulated genes in small cell lung cancer, a highly metastatic lung cancer subtype, compared to NSCLC [52], implying that ACBD3 may act as a negative regulator of lung cancer metastasis. This evidence concerns the gene ACBD3 and lung cancer.